Treating Acne Scars in Fitzpatrick Skin Types I–VI Using a Novel 1550 nm Non‐Ablative Resurfacing Laser With Focal Point Technology
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70620 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Jordan V Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laser & Skin Surgery Center of Pennsylvania, Devon, Pennsylvania, USA. Hauptthemen laut MEDLINE: Acne Vulgaris, Cicatrix, Laser Therapy, Lasers, Solid-State. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AVAVA.
Abstract (Originalsprache)
Background
Acne scars have traditionally been treated with non‐ablative fractional resurfacing lasers. Traditional 1550 nm lasers can be limited in energy delivery, skin cooling, and safety across all skin types. A new‐generation 1550 nm non‐ablative resurfacing laser was recently developed, employing conical beams for high energy delivery through Focal Point Technology.
Objective
To evaluate the utility of a 1550 nm non‐ablative resurfacing laser using Focal Point Technology to improve acne scars in Fitzpatrick skin types I–VI. Methods and Materials A prospective, multi‐center clinical study investigated this novel resurfacing laser using 1–6 treatments.
Results
Forty‐seven subjects with Fitzpatrick skin types I–VI were enrolled and treated. Mean age was 40.2 years, and 59.6% were women. Based on GAIS, 78.0% were rated as improved, with none worsening. Two of three blinded reviewers correctly identified photographs for 92.7% of subjects. Significant improvement in blinded ECCA score was observed (85.6 vs. 55.3; p < 0.0001), with 90.2% achieving at least a 15‐point improvement. Treatments were well tolerated.
Conclusion
This new‐generation 1550 nm non‐ablative laser using Focal Point Technology with high energy delivery is safe and effective for acne scar treatment in all Fitzpatrick skin types. Its conical beams and cooling system significantly reduce hyperpigmentation risk in darker skin types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laser & Skin Surgery Center of Pennsylvania, Devon, Pennsylvania, USA.
- Office of Roy G Geronemus, New York, New York, USA.
- VivaSkin Dermatology and Aesthetics, Wellesley, Massachusetts, USA.
- Department of Dermatology, Wellman Laboratories of Photomedicine, Harvard Medical School, Boston, Massachusetts, USA.
- Callender Dermatology and Cosmetic Center, Glenn Dale, Maryland, USA.
- Howard University College of Medicine, Washington, DC, USA.
ORCID-Profile: Jordan V Wang
Förderung
- AVAVA
Zitieren
APA
Wang, J. V., Pomerantz, H., Tran, T. N., Callender, V., Weiss, R., Weiss, M., Bowes, L., & Geronemus, R. G. (2025). Treating Acne Scars in Fitzpatrick Skin Types I–VI Using a Novel 1550 nm Non‐Ablative Resurfacing Laser With Focal Point Technology. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70620
Vancouver
Wang JV, Pomerantz H, Tran TN, Callender V, Weiss R, Weiss M, et al. Treating Acne Scars in Fitzpatrick Skin Types I–VI Using a Novel 1550 nm Non‐Ablative Resurfacing Laser With Focal Point Technology. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70620
BibTeX
@article{Wang2025,
author = {Wang, Jordan V and Pomerantz, Hyemin and Tran, Thanh-Nga and Callender, Valerie and Weiss, Robert and Weiss, Margaret and Bowes, Leyda and Geronemus, Roy G},
title = {Treating Acne Scars in Fitzpatrick Skin Types I–VI Using a Novel 1550 nm Non‐Ablative Resurfacing Laser With Focal Point Technology},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70620}
}
EUVIMED